The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Åke Borg

Åke Borg

Principal investigator

Åke Borg

Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.

Author

  • Ulrika Andersson
  • Carl Wibom
  • Kristina Cederquist
  • Steina Aradottir
  • Åke Borg
  • Georgina N Armstrong
  • Sanjay Shete
  • Ching C Lau
  • Matthew N Bainbridge
  • Elizabeth B Claus
  • Jill Barnholtz-Sloan
  • Rose Lai
  • Dora Il'yasova
  • Richard S Houlston
  • Joellen Schildkraut
  • Jonine L Bernstein
  • Sara H Olson
  • Robert B Jenkins
  • Daniel H Lachance
  • Margaret Wrensch
  • Faith G Davis
  • Ryan Merrell
  • Christoffer Johansen
  • Siegal Sadetzki
  • Melissa L Bondy
  • Beatrice S Melin

Summary, in English

Although familial susceptibility to glioma is known, the genetic basis for this susceptibility remains unidentified in the majority of glioma-specific families. An alternative approach to identifying such genes is to examine cancer pedigrees, which include glioma as one of several cancer phenotypes, to determine whether common chromosomal modifications might account for the familial aggregation of glioma and other cancers.

Department/s

  • Breastcancer-genetics
  • BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation

Publishing year

2014

Language

English

Pages

1333-1340

Publication/Series

Neuro-Oncology

Volume

16

Issue

10

Document type

Journal article

Publisher

Oxford University Press

Topic

  • Cancer and Oncology

Status

Published

ISBN/ISSN/Other

  • ISSN: 1523-5866